152 related articles for article (PubMed ID: 33036456)
41. [Correlation between the biofilm-forming ability, biofilm-related genes and antimicrobial resistance of Acinetobacter baumannii].
Han X; Li Q; Shen L; Hu D; Qu Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Sep; 26(9):639-43. PubMed ID: 25230865
[TBL] [Abstract][Full Text] [Related]
42. [Antiseptic effect of compound lysostaphin disinfectant and its preventive effect on infection of artificial dermis after graft on full-thickness skin defect wound in rats].
Jin J; Zhou H; Cui ZC; Wang L; Luo PF; Ji SZ; Hu XY; Ma B; Wang GY; Zhu SH; Xia ZF
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):225-232. PubMed ID: 29690741
[No Abstract] [Full Text] [Related]
43. Humanized Exposures of a β-Lactam-β-Lactamase Inhibitor, Tazobactam, versus Non-β-Lactam-β-Lactamase Inhibitor, Avibactam, with or without Colistin, against Acinetobacter baumannii in Murine Thigh and Lung Infection Models.
Monogue ML; Sakoulas G; Nizet V; Nicolau DP
Pharmacology; 2018; 101(5-6):255-261. PubMed ID: 29533955
[TBL] [Abstract][Full Text] [Related]
44. Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates.
Bardbari AM; Arabestani MR; Karami M; Keramat F; Alikhani MY; Bagheri KP
Microb Pathog; 2017 Jul; 108():122-128. PubMed ID: 28457900
[TBL] [Abstract][Full Text] [Related]
45. Bactericidal activity of herbal volatile oil extracts against multidrug-resistant
Intorasoot A; Chornchoem P; Sookkhee S; Intorasoot S
J Intercult Ethnopharmacol; 2017; 6(2):218-222. PubMed ID: 28512603
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of Trans-cinnamaldehyde and Eugenol in Reducing Acinetobacter baumannii Adhesion to and Invasion of Human Keratinocytes and Controlling Wound Infection In Vitro.
Karumathil DP; Surendran-Nair M; Venkitanarayanan K
Phytother Res; 2016 Dec; 30(12):2053-2059. PubMed ID: 27619325
[TBL] [Abstract][Full Text] [Related]
47. Anti-multidrug-resistant Acinetobacter baumannii activity of DS-8587: In vitro activity and in vivo efficacy in a murine calf muscle infection model.
Higuchi S; Kurosaka Y; Uoyama S; Yoshida K; Chiba M; Ishii C; Fujikawa K; Karibe Y; Hoshino K
J Infect Chemother; 2014 May; 20(5):312-6. PubMed ID: 24594453
[TBL] [Abstract][Full Text] [Related]
48. Antimicrobial and antibiofilm activities of Clostridium butyricum supernatant against Acinetobacter baumannii.
Shin DS; Eom YB
Arch Microbiol; 2020 Jul; 202(5):1059-1068. PubMed ID: 32020245
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of Poloxamer-Based Wound Dressings on
Salisbury AM; Mullin M; Chen R; Percival SL
Adv Wound Care (New Rochelle); 2019 Oct; 8(10):463-468. PubMed ID: 31456903
[No Abstract] [Full Text] [Related]
50. In vitro reduction of antibacterial activity of tigecycline against multidrug-resistant Acinetobacter baumannii with host stress hormone norepinephrine.
Inaba M; Matsuda N; Banno H; Jin W; Wachino JI; Yamada K; Kimura K; Arakawa Y
Int J Antimicrob Agents; 2016 Dec; 48(6):680-689. PubMed ID: 27842757
[TBL] [Abstract][Full Text] [Related]
51. New Shuttle Vectors for Real-Time Gene Expression Analysis in Multidrug-Resistant Acinetobacter Species:
Lucidi M; Visaggio D; Prencipe E; Imperi F; Rampioni G; Cincotti G; Leoni L; Visca P
Appl Environ Microbiol; 2019 Sep; 85(18):. PubMed ID: 31324623
[TBL] [Abstract][Full Text] [Related]
52. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
[TBL] [Abstract][Full Text] [Related]
53. [Investigation of oxacillinase genes in nosocomial multidrug-resistant Acinetobacter baumannii isolates by multiplex PCR and evaluation of their clonal relationship with Rep-PCR].
Sarı B; Baran I; Alaçam S; Mumcuoğlu İ; Kurşun Ş; Aksu N
Mikrobiyol Bul; 2015 Apr; 49(2):249-58. PubMed ID: 26167825
[TBL] [Abstract][Full Text] [Related]
54. Chemical composition, anti-biofilm activity and potential cytotoxic effect on cancer cells of Rosmarinus officinalis L. essential oil from Tunisia.
Jardak M; Elloumi-Mseddi J; Aifa S; Mnif S
Lipids Health Dis; 2017 Oct; 16(1):190. PubMed ID: 28969677
[TBL] [Abstract][Full Text] [Related]
55. Identification and characterization of novel isothiazolones with potent bactericidal activity against multi-drug resistant Acinetobacter baumannii clinical isolates.
Luna BL; Garcia JA; Huang M; Ewing PJ; Valentine SC; Chu YM; Ye QZ; Xu HH
Int J Antimicrob Agents; 2019 Apr; 53(4):474-482. PubMed ID: 30593847
[TBL] [Abstract][Full Text] [Related]
56. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
Boral B; Unaldi Ö; Ergin A; Durmaz R; Eser ÖK;
Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):19. PubMed ID: 31266519
[TBL] [Abstract][Full Text] [Related]
57. Fluorescence-Based Detection of Natural Transformation in Drug-Resistant Acinetobacter baumannii.
Godeux AS; Lupo A; Haenni M; Guette-Marquet S; Wilharm G; Laaberki MH; Charpentier X
J Bacteriol; 2018 Oct; 200(19):. PubMed ID: 30012729
[No Abstract] [Full Text] [Related]
58. Activity of levofloxacin in combination with colistin against Acinetobacter baumannii: In vitro and in a Galleria mellonella model.
Wei W; Yang H; Hu L; Ye Y; Li J
J Microbiol Immunol Infect; 2017 Dec; 50(6):821-830. PubMed ID: 26725481
[TBL] [Abstract][Full Text] [Related]
59. Clinical isolates of Acinetobacter baumannii from a Portuguese hospital: PFGE characterization, antibiotic susceptibility and biofilm-forming ability.
Duarte A; Ferreira S; Almeida S; Domingues FC
Comp Immunol Microbiol Infect Dis; 2016 Apr; 45():29-33. PubMed ID: 27012918
[TBL] [Abstract][Full Text] [Related]
60. Elevated prevalence of multidrug-resistant Acinetobacter baumannii with extensive genetic diversity in the largest burn centre of northeast Iran.
Sarhaddi N; Soleimanpour S; Farsiani H; Mosavat A; Dolatabadi S; Salimizand H; Amel Jamehdar S
J Glob Antimicrob Resist; 2017 Mar; 8():60-66. PubMed ID: 28011349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
